Evidence map›Paper›PMID 35793919›Full record

ArticleBMJ open2022

Impetus of US hospital leaders to invest in patient-reported outcome measures (PROMs): a qualitative study.

Danny Mou, Christer Mjaset, Claire M Sokas, Azan Virji, Barbara Bokhour, Marilyn Heng, Rachel C Sisodia, Andrea L Pusic, Meredith B Rosenthal

Abstract read
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Danny MouSurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA moudanny@gmail.com.ORCID 0000-0003-3529-3563
Christer MjasetHarvard University T H Chan School of Public Health, Boston, Massachusetts, USA.
Claire M SokasSurgery, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Azan VirjiHarvard Medical School, Boston, Massachusetts, USA.
Barbara BokhourPopulation and Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Marilyn HengOrthopaedic Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.ORCID 0000-0002-4047-6818
Rachel C SisodiaPhysician Organization, Massachusetts General Hospital, Boston, Massachusetts, USA.
Andrea L PusicDivision of Plastic and Reconstructive Surgery, Patient Reported Outcome Value and Experience (PROVE) Center, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Meredith B RosenthalDepartment of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThough hospital leaders across the USA have invested significant resources in collection of patient-reported outcome measures (PROMs), there are very limited data on the impetus for hospital leadership to establish PROM programmes. In this qualitative study, we identify the drivers and motivators of PROM collection among hospital leaders in the USA.

designExploratory qualitative study.

settingThirty-seven hospital leaders representing seven different institutions with successful PROMs programs across twenty US states.

methodsSemistructured interviews conducted with hospital leaders. Transcripts were analysed using thematic analysis.

resultsLeaders strongly believe that collecting PROMs is the 'right thing to do' and that the culture of the institution plays an important role in enabling PROMs. The study participants often believe that their institutions deliver superior care and that PROMs can be used to demonstrate the value of their services to payors and patients. Direct financial incentives are relatively weak motivators for collection of PROMs. Most hospital leaders have reservations about using PROMs in their current state as a meaningful performance metric.

conclusionThese findings suggest that hospital leaders feel a strong moral imperative to collect PROMs, which is also supported by the culture of their institution. Although PROMs are used in negotiations with payors, direct financial return on investment is not a strong driver for the collection of PROMs. Understanding why leaders of major healthcare institutions invest in PROMs is critical to understanding the role that PROMs play in the US healthcare system.

Indexed as

Health FacilitiesHospitalsEmotionsHumansPatient Reported Outcome MeasuresQualitative ResearchChange managementHealth economicsHealth policyHealth & safetyQUALITATIVE RESEARCHQuality in health care

Identifiers

PMID35793919
PMCPMC9260769

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.